BIT
ARGS

BlackRock Institutional Trust’s Argos Therapeutics, Inc. ARGS Stock Holding History

BlackRock Institutional Trust’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$732K Buy
7,465
+1,750
+31% +$164K ﹤0.01% 3372
2016
Q3 		$568K Buy
5,715
+2,758
+93% +$288K ﹤0.01% 3455
2016
Q2 		$363K Buy
+2,957
New +$395K ﹤0.01% 3555
2014
Q2 		– Sell
-1,749
Closed -$350K – 4160
2014
Q1 		$350K Buy
+1,749
New +$350K ﹤0.01% 3630

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's ARGS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Argos Therapeutics, Inc. (ARGS) stake by 31% in Q4 2016, buying an estimated $164K and bringing the position to 7,465 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #3372.

BlackRock Institutional Trust first reported a position in ARGS in Q1 2014 and has held it in 4 quarters since. 52 funds tracked by Wall St. Rank hold ARGS as of Q4 2016.

  • BlackRock Institutional Trust held 7,465 shares of Argos Therapeutics, Inc. worth $732K as of Q4 2016.
  • BlackRock Institutional Trust bought 1,750 Argos Therapeutics, Inc. shares in Q4 2016, an estimated $164K.
  • Argos Therapeutics, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3372 holding.
  • BlackRock Institutional Trust first reported a position in Argos Therapeutics, Inc. in Q1 2014 and has held it in 4 quarters since.
  • 52 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.